BlackRock’s Core Scientific, Inc. Common Stock CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,542,226
Closed -$21.5M 5893
2022
Q3
$21.5M Buy
16,542,226
+2,090,976
+14% +$4.45M ﹤0.01% 2994
2022
Q2
$21.5M Buy
14,451,250
+11,269,528
+354% +$51.8M ﹤0.01% 3051
2022
Q1
$26.2M Sell
3,181,722
-233,778
-7% -$2.06M ﹤0.01% 2997
2021
Q4
$37.4M Hold
3,415,500
﹤0.01% 2860
2021
Q3
$34.5M Hold
3,415,500
﹤0.01% 2904
2021
Q2
$33.6M Buy
+3,415,500
New +$33.7M ﹤0.01% 2971

Other funds holding CORZ

BlackRock's CORZ Position: Q4 2022 in Review

BlackRock sold out of Core Scientific, Inc. Common Stock (CORZ) in Q4 2022, closing a stake of 16,542,226 shares — an estimated $21.5M sold.

BlackRock first reported a position in CORZ in Q2 2021 and held it in 6 quarters. The position peaked at $37.4M in Q4 2021. 89 funds tracked by Wall St. Rank hold CORZ as of Q4 2022.

  • BlackRock reported no remaining Core Scientific, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • BlackRock sold 16,542,226 Core Scientific, Inc. Common Stock shares in Q4 2022, an estimated $21.5M.
  • BlackRock first reported a position in Core Scientific, Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • BlackRock's Core Scientific, Inc. Common Stock position peaked at $37.4M in Q4 2021.
  • 89 funds tracked by Wall St. Rank held Core Scientific, Inc. Common Stock as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.